Molecular & Cellular Proteomics,
Год журнала:
2021,
Номер
21(1), С. 100179 - 100179
Опубликована: Ноя. 20, 2021
Single-cell
tandem
MS
has
enabled
analyzing
hundreds
of
single
cells
per
day
and
quantifying
thousands
proteins
across
the
cells.
The
broad
dissemination
these
capabilities
can
empower
dissection
pathophysiological
mechanisms
in
heterogeneous
tissues.
Key
requirements
for
achieving
this
goal
include
robust
protocols
performed
on
widely
accessible
hardware,
quality
controls,
community
standards,
automated
data
analysis
pipelines
that
pinpoint
analytical
problems
facilitate
their
timely
resolution.
Toward
meeting
requirements,
perspective
outlines
both
existing
resources
outstanding
opportunities,
such
as
parallelization,
catalyzing
wide
quantitative
single-cell
proteomics
be
scaled
up
to
tens
Indeed,
simultaneous
parallelization
peptides
is
a
promising
approach
multiplicative
increase
speed
performing
deep
proteomics.
ready
begin
virtuous
cycle
increased
adoption
fueling
development
more
technology
turn
drive
broader
adoption,
scientific
discoveries,
clinical
applications.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Июль 8, 2022
The
dia-PASEF
technology
uses
ion
mobility
separation
to
reduce
signal
interferences
and
increase
sensitivity
in
proteomic
experiments.
Here
we
present
a
two-dimensional
peak-picking
algorithm
generation
of
optimized
spectral
libraries,
as
well
take
advantage
neural
network-based
processing
data.
Our
computational
platform
boosts
depth
by
up
83%
compared
previous
work,
is
specifically
beneficial
for
fast
experiments
those
with
low
sample
amounts.
It
quantifies
over
5300
proteins
single
injections
recorded
at
200
samples
per
day
throughput
using
Evosep
One
chromatography
system
on
timsTOF
Pro
mass
spectrometer
almost
9000
93-min
nanoflow
gradient
2,
from
ng
HeLa
peptides.
A
user-friendly
implementation
provided
through
the
incorporation
algorithms
DIA-NN
software
FragPipe
workflow
library
generation.
Journal of Proteome Research,
Год журнала:
2021,
Номер
20(12), С. 5241 - 5263
Опубликована: Окт. 21, 2021
The
study
of
proteins
circulating
in
blood
offers
tremendous
opportunities
to
diagnose,
stratify,
or
possibly
prevent
diseases.
With
recent
technological
advances
and
the
urgent
need
understand
effects
COVID-19,
proteomic
analysis
blood-derived
serum
plasma
has
become
even
more
important
for
studying
human
biology
pathophysiology.
Here
we
provide
views
perspectives
about
developments
possible
clinical
applications
that
use
mass-spectrometry(MS)-
affinity-based
methods.
We
discuss
examples
where
proteomics
contributed
valuable
insights
into
SARS-CoV-2
infections,
aging,
hemostasis
offered
by
combining
with
genetic
data.
As
a
contribution
Human
Proteome
Organization
(HUPO)
Plasma
Project
(HPPP),
present
PeptideAtlas
build
2021-07
comprises
4395
canonical
1482
additional
nonredundant
detected
240
MS-based
experiments.
In
addition,
report
new
Extracellular
Vesicle
2021-06,
which
five
studies
2757
extracellular
vesicles
blood,
74%
(2047)
are
common
PeptideAtlas.
Our
overview
summarizes
advances,
impactful
applications,
ongoing
challenges
translating
utility
precision
medicine.
Molecular & Cellular Proteomics,
Год журнала:
2021,
Номер
20, С. 100138 - 100138
Опубликована: Янв. 1, 2021
Recent
advances
in
efficiency
and
ease
of
implementation
have
rekindled
interest
ion
mobility
spectrometry,
a
technique
that
separates
gas
phase
ions
by
their
size
shape
can
be
hybridized
with
conventional
LC
MS.
Here,
we
review
the
recent
development
trapped
spectrometry
(TIMS)
coupled
to
TOF
mass
analysis.
In
particular,
parallel
accumulation–serial
fragmentation
(PASEF)
operation
mode
offers
unique
advantages
terms
sequencing
speed
sensitivity.
Its
defining
feature
is
it
synchronizes
release
from
TIMS
device
downstream
selection
precursors
for
quadrupole
configuration.
As
are
compressed
into
narrow
peaks,
number
peptide
fragment
spectra
obtained
data-dependent
or
targeted
analyses
increased
an
order
magnitude
without
compromising
Taking
advantage
correlation
between
mass,
PASEF
principle
also
multiplies
data-independent
acquisition.
This
makes
technology
well
suited
rapid
proteome
profiling,
increasingly
important
attribute
clinical
proteomics,
as
ultrasensitive
measurements
down
single
cells.
The
accuracy
enable
precise
collisional
cross
section
values
at
scale
more
than
million
data
points
neural
networks
capable
predicting
them
based
only
on
sequences.
Peptide
differ
isobaric
sequences
positional
isomers
post-translational
modifications.
additional
information
may
leveraged
real
time
direct
acquisition
postprocessing
increase
confidence
identifications.
These
developments
make
powerful
expandable
platform
proteomics
beyond.
Nature Biotechnology,
Год журнала:
2024,
Номер
unknown
Опубликована: Фев. 1, 2024
Abstract
Mass
spectrometry
(MS)-based
proteomics
aims
to
characterize
comprehensive
proteomes
in
a
fast
and
reproducible
manner.
Here
we
present
the
narrow-window
data-independent
acquisition
(nDIA)
strategy
consisting
of
high-resolution
MS1
scans
with
parallel
tandem
MS
(MS/MS)
~200
Hz
using
2-Th
isolation
windows,
dissolving
differences
between
data-dependent
-independent
methods.
This
is
achieved
by
pairing
quadrupole
Orbitrap
mass
spectrometer
asymmetric
track
lossless
(Astral)
analyzer
which
provides
>200-Hz
MS/MS
scanning
speed,
high
resolving
power
sensitivity,
low-ppm
accuracy.
The
nDIA
enables
profiling
>100
full
yeast
per
day,
or
48
human
day
at
depth
~10,000
protein
groups
half-an-hour
~7,000
proteins
5
min,
representing
3×
higher
coverage
compared
current
state-of-the-art
MS.
Multi-shot
offline
fractionated
samples
~3
h.
High
quantitative
precision
accuracy
are
demonstrated
three-species
proteome
mixture,
quantifying
14,000+
single
run.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Июль 27, 2023
Peptide
identification
in
liquid
chromatography-tandem
mass
spectrometry
(LC-MS/MS)
experiments
relies
on
computational
algorithms
for
matching
acquired
MS/MS
spectra
against
sequences
of
candidate
peptides
using
database
search
tools,
such
as
MSFragger.
Here,
we
present
a
new
tool,
MSBooster,
rescoring
peptide-to-spectrum
matches
additional
features
incorporating
deep
learning-based
predictions
peptide
properties,
LC
retention
time,
ion
mobility,
and
spectra.
We
demonstrate
the
utility
tandem
with
MSFragger
Percolator,
several
different
workflows,
including
nonspecific
searches
(immunopeptidomics),
direct
from
data
independent
acquisition
data,
single-cell
proteomics,
generated
an
mobility
separation-enabled
timsTOF
MS
platform.
MSBooster
is
fast,
robust,
fully
integrated
into
widely
used
FragPipe
Mass Spectrometry Reviews,
Год журнала:
2022,
Номер
42(6), С. 2324 - 2348
Опубликована: Май 29, 2022
Abstract
The
data‐independent
acquisition
mass
spectrometry
(DIA‐MS)
has
rapidly
evolved
as
a
powerful
alternative
for
highly
reproducible
proteome
profiling
with
unique
strength
of
generating
permanent
digital
maps
retrospective
analysis
biological
systems.
Recent
advancements
in
data
software
tools
the
complex
DIA‐MS/MS
spectra
coupled
to
fast
MS
scanning
speed
and
high
accuracy
have
greatly
expanded
sensitivity
coverage
DIA‐based
proteomics
profiling.
Here,
we
review
evolution
DIA‐MS
techniques,
from
earlier
proof‐of‐principle
parallel
fragmentation
all‐ions
or
ions
selected
m
/
z
range,
sequential
window
all
theoretical
(SWATH‐MS)
latest
innovations,
recent
development
computation
algorithms
informatics,
auxiliary
advanced
instrumentation
enhance
performance
DIA‐MS.
We
further
summarize
applications
experimentally‐derived
well
silico
library
resources
large‐scale
facilitate
biomarker
discovery
drug
human
diseases
emphasis
on
proteomic
coverage.
Toward
next‐generation
clinical
proteomics,
outline
challenges
processing
multi‐dimensional
DIA
set
continuing
need
higher
sensitivity.
Nature Microbiology,
Год журнала:
2022,
Номер
7(4), С. 542 - 555
Опубликована: Март 21, 2022
Abstract
Microbial
communities
are
composed
of
cells
varying
metabolic
capacity,
and
regularly
include
auxotrophs
that
lack
essential
pathways.
Through
analysis
for
amino
acid
biosynthesis
pathways
in
microbiome
data
derived
from
>12,000
natural
microbial
obtained
as
part
the
Earth
Microbiome
Project
(EMP),
study
auxotrophic–prototrophic
interactions
self-establishing
metabolically
cooperating
yeast
(SeMeCos),
we
reveal
a
imprinted
mechanism
links
presence
to
an
increase
gains
antimicrobial
drug
tolerance.
As
consequence
adaptations
necessary
uptake
specific
metabolites,
obtain
altered
flux
distributions,
export
more
metabolites
and,
this
way,
enrich
community
environments
metabolites.
Moreover,
increased
efflux
activities
reduce
intracellular
concentrations,
allowing
grow
levels
above
minimal
inhibitory
concentrations.
For
example,
show
antifungal
action
azoles
is
greatly
diminished
enriched
environment.
Our
results
hence
provide
explains
why
robust
exposure
when
they
interact
metabolically.
Molecular & Cellular Proteomics,
Год журнала:
2023,
Номер
22(7), С. 100577 - 100577
Опубликована: Май 19, 2023
Accurate
biomarkers
are
a
crucial
and
necessary
precondition
for
precision
medicine,
yet
existing
ones
often
unspecific
new
have
been
very
slow
to
enter
the
clinic.
Mass
spectrometry
(MS)-based
proteomics
excels
by
its
untargeted
nature,
specificity
of
identification,
quantification,
making
it
an
ideal
technology
biomarker
discovery
routine
measurement.
It
has
unique
attributes
compared
affinity
binder
technologies,
such
as
OLINK
Proximity
Extension
Assay
SOMAscan.
In
in
previous
review
2017,
we
described
technological
conceptual
limitations
that
had
held
back
success.
We
proposed
'rectangular
strategy'
better
separate
true
minimizing
cohort-specific
effects.
Today,
this
converged
with
advances
MS-based
technology,
increased
sample
throughput,
depth
quantification.
As
result,
studies
become
more
successful,
producing
candidates
withstand
independent
verification
and,
some
cases,
already
outperform
state-of-the-art
clinical
assays.
summarize
developments
over
last
years,
including
benefits
large
cohorts,
which
acceptance.
Shorter
gradients,
scan
modes,
multiplexing
about
drastically
increase
cross-study
integration,
proxies
absolute
levels.
found
multiprotein
panels
inherently
robust
than
current
single
analyte
tests
capture
complexity
human
phenotypes.
Routine
MS
measurement
clinic
is
fast
becoming
viable
option.
The
full
set
proteins
body
fluid
(global
proteome)
most
important
reference
best
process
control.
Additionally,
increasingly
all
information
could
be
obtained
from
targeted
analysis
although
latter
may
straightforward
way
regular
use.
Many
challenges
remain,
not
least
regulatory
ethical
but
outlook
applications
never
brighter.